Assistant Professor of Medicine, Johns Hopkins University School of Medicine; Robert Meyerhoff Assistant Professor of Medicine
Infectious Disease
Dr. Michael A. Chattergoon, MD
|
|
Give Review
Michael Chattergoon is an expert in the field of Infectious Disease. He attended Perelman School of Medicine at the University of Pennsylvania. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Michael A. Chattergoon, MD is also a published doctor. He has 41 paper published. The most recent paper is: Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon.
- Monocytes Activate Natural Killer Cells via Inflammasome-induced Interleukin 18 in Response to Hepatitis C Virus Replication.
- Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection.
- High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection.
- HIV-Mediated Phosphatidylinositol 3-Kinase/Serine-Threonine Kinase Activation in APCs Leads to Programmed Death-1 Ligand Upregulation and Suppression of HIV-Specific C...
- DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo.
- Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.
- Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.
- Mechanism of HIV-1 viral protein R-induced apoptosis.
- Plasmid immunization primes unique DTH responses to HIV-1MN envelope epitopes as compared to recombinant protein vaccination.
- Engineering of DNA vaccines using molecular adjuvant plasmids.
- Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis.
- Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant ch...
- Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial.
- Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine.
- HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.
- Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.
- DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans.
- First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.
- Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.
- Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation.
- Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens.
- Monoclonal antibodies define a cellular antigen involved in HTLV-I infection.
- DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees.
- Genetic immunization: a new era in vaccines and immune therapeutics.
- Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees.
- Development of a multicomponent candidate vaccine for HIV-1.
- Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes.
- Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.
- In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.
- Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.
- Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice.
- Prospects for an HIV vaccine: conventional approaches and DNA immunization.
- Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin.
- Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines.
- Engineering cross-presentation in vivo.
- Next generation DNA vaccines for HIV-1.
- Plasmid DNA: is there a Toll on the way to apoptosis?
- Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway.
- HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
Schools
Perelman School of Medicine University of Pennsylvania
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1801959390 | |
| NPPES Provider LastName | CHATTERGOON | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 23.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801959390 |
| Last Name Of The Provider | CHATTERGOON |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Lori E. Fantry, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelley S. Magill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luciano Kapelusznik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clayton L. Moravec Jr., MD |
|
|
Dr. Ronald B. Reisler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fiona Havers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Melia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen R. Page, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirsten E. Lyke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy M. Hardy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kerri A. Thom, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David W. Oldach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Thomas Inglesby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chloe L. Thio, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Simon Dufresne, MD
This Doctor is OpenDoctor Recommended.
|